Suchergebnisse

There are plenty of choices in the Mid Cap Growth category, but where should you start your research? Well, one fund that might be worth investigating is Carillon Eagle Mid Cap Growth R6 (HRAUX)

Herc Holdings (HRI) is expected to deliver a year-over-year decline in earnings on higher revenues when it reports results for the quarter ended March 2026. This widely-known consensus outlook

Herc Holdings (HRI) came out with quarterly earnings of $0.21 per share, beating the Zacks Consensus Estimate of a loss of $1.02 per share. This compares to earnings of $1.3 per share a year ago

Investors looking for stocks in the Transportation - Equipment and Leasing sector might want to consider either AerCap (AER) or Herc Holdings (HRI). But which of these two stocks is more attractive

Harmony Biosciences Holdings, Inc. (HRMY) closed the last trading session at $31.83, gaining 14.7% over the past four weeks, but there could be plenty of upside left in the stock if short-term price

Wall Street expects a year-over-year decline in earnings on higher revenues when Harrow (HROW) reports results for the quarter ended March 2026. While this widely-known consensus outlook is

Wall Street expects a year-over-year decline in earnings on lower revenues when Heron Therapeutics (HRTX) reports results for the quarter ended March 2026. While this widely-known consensus outlook

Investors looking for stocks in the Medical - Biomedical and Genetics sector might want to consider either Harmony Biosciences Holdings, Inc. (HRMY) or argenex SE (ARGX). But which of these two

Horizon Technology Finance (HRZN) came out with quarterly earnings of $0.19 per share, in line with the Zacks Consensus Estimate . This compares to earnings of $0.27 per share a year ago. These

H&R Block (HRB) came out with quarterly earnings of $6.02 per share, beating the Zacks Consensus Estimate of $5.69 per share. This compares to earnings of $5.38 per share a year ago. These figures

H&R Block (HRB) reported $2.4 billion in revenue for the quarter ended March 2026, representing a year-over-year increase of 5.3%. EPS of $6.02 for the same period compares to $5.38 a year ago.

The

Harmony Biosciences Holdings, Inc. (HRMY) came out with quarterly earnings of $0.55 per share, missing the Zacks Consensus Estimate of $0.76 per share. This compares to earnings of $0.78 per share a

H&R Block Inc. HRB reported impressive third-quarter fiscal 2026 results, with both earnings and revenues beating the Zacks Consensus Estimate.

HRB’s adjusted earnings of $6.02 per share beat the